| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.86B | -12.3% |
| Cost of Revenue | $1.55B | -13.8% |
| Gross Profit | $312.5M | -4.2% |
| R&D Expense | $40.8M | +19.3% |
| SG&A Expense | $220.7M | -22.9% |
| Operating Income | $6.3M | +121.3% |
| Pre-tax Income | $6.6M | +125.1% |
| Income Tax | $7.0M | -46.6% |
| Net Income | -$400K | +99.0% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $288.7M | -12.9% |
| Short-term Investments | $58.9M | — |
| Accounts Receivable | $357.9M | -4.6% |
| Inventory | $15.5M | +30.3% |
| Current Assets | $778.4M | -6.7% |
| Total Assets | $915.7M | -2.1% |
| Current Liabilities | $523.2M | -11.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $29.1M | -30.5% |
| Capital Expenditures | $13.1M | +197.7% |
| Investing Cash Flow | -$73.0M | -1487.0% |
| Financing Cash Flow | $1.1M | -98.7% |
| Free Cash Flow | $16.0M | -57.3% |
| Total Liabilities |
| $542.0M |
| -10.4% |
| Stockholders' Equity | $373.7M | +13.0% |